ED
KOD icon

Exane Derivatives’s Kodiak Sciences KOD Stock Holding History

Exane Derivatives’s Portfolio KOD Stock Details KOD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-943
Closed -$79.9K – 1058
2021
Q4 		$79.9K Buy
943
+932
+8,473% +$94.8K 0.02% 454
2021
Q3 		$1.06K Hold
11
– – ﹤0.01% 857
2021
Q2 		$1.02K Sell
11
-760
-99% -$72.9K ﹤0.01% 876
2021
Q1 		$87.4K Sell
771
-1,305
-63% -$178K 0.03% 439
2020
Q4 		$305K Sell
2,076
-491
-19% -$54.7K 0.09% 243
2020
Q3 		$152K Sell
2,567
-221
-8% -$11.1K 0.04% 238
2020
Q2 		$151K Sell
2,788
-628
-18% -$35.4K 0.04% 237
2020
Q1 		$163K Buy
+3,416
New +$205K 0.05% 222

Other funds holding KOD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Exane Derivatives's KOD Position: Q1 2022 in Review

Exane Derivatives sold out of Kodiak Sciences (KOD) in Q1 2022, closing a stake of 943 shares — an estimated $79.9K sold.

Exane Derivatives first reported a position in KOD in Q1 2020 and held it in 8 quarters. The position peaked at $305K in Q4 2020. 142 funds tracked by Wall St. Rank hold KOD as of Q1 2022.

  • Exane Derivatives reported no remaining Kodiak Sciences position as of Q1 2022 after selling out during the quarter.
  • Exane Derivatives sold 943 Kodiak Sciences shares in Q1 2022, an estimated $79.9K.
  • Exane Derivatives first reported a position in Kodiak Sciences in Q1 2020 and held it in 8 quarters.
  • Exane Derivatives's Kodiak Sciences position peaked at $305K in Q4 2020.
  • 142 funds tracked by Wall St. Rank held Kodiak Sciences as of Q1 2022.

Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.